Skip to main content
. 2019 Jan 1;2019:9645147. doi: 10.1155/2019/9645147

Table 2.

The characteristics of the groups.

Characteristics n BRCA1/BRCA2 BRCA1 BRCA2
Negative Positive Negative Positive p Negative Positive p
Age [mean (min-max)] 46 (28-82) 43.7 (27-63) 45.7 45.5 0.781 46.0 41.4 0.190
Germline mutation 81 (81%) 19 (19%) 88 (88%) 11 (11%) 91 (91%) 8 (8%)
Family History 21 17 (81%) 4 (19%) 19 (90.5%) 2 (9.5%) 1.000 19 (90.5%) 2 (9. 5%) 1.000
Bilateral breast carcinoma 7 6 (86%) 1 (14%) 7 0 0.351 6 (86%) 1 (14%) 1.000
Breast + ovarian carcinoma 7 4 (67.2%) 3 (42.8%) 5 (71.5%) 2 (28.5%) 0.173 6 (85.8%) 1 (14.2%) 0.456
Triple-negative tumor 33 25 (75.7%) 8 (24.2%) 27 (81.8%) 6 (18.1%) 0.172 31 (93.9%) 2 (6.0%) 0.715
Below 40 years old 41 33 (80.4%) 8 (19.5%) 37 (90.2%) 4 (9.5%) 1.000 37 (90.2%) 4 (9.5%) 0.715
Triple negative + below 40 years old 8 5 (62.5%) 3 (37.5%) 6 (75%) 2 (25%) 7 (87.5%) 1 (12.5%)
ER Positive 60 51 (85%) 9 (15%) 56 (93.3%) 4 (6.6%) 0.316 55 (91.6%) 5 (8.33%) 0.824
ER Negative 39 29 (74.3%) 10 (25%) 32 (82%) 7 (17.9%) 36 (92.3%) 3 (7.6%)
PR Positive 53 45 (84.9%) 8 (15%) 49 (92.4%) 4 (7.5%) 0.526 49 (92.4%) 4 (7.5%) 1.000
PR Negative 46 35 (76%) 11 (23.9%) 39 (84.7%) 7 (15.2%) 42 (91.3%) 4 (8.6%)
HER 2 Positive 10 10 (100%) 0 10 (100%) 0 0.650 10 (100%) 0 1.000
Right Breast 47 36 (76.5%) 11 (23.4%) 39 (82.9%) 8 (17%) 0.262 44 (93.6%) 3 (6.3%) 0.710
Left Breast 45 37 (82.2%) 8 (17.7%) 42 (93.3%) 3 (6.6%) 40 (88.8%) 5 (11.1%)
Invasive Ductal Carcinoma 86 69 (80%) 17 (19%) 75 (87%) 11 (12%) 0.351 80 (93%) 6 (6.9%) 0.245
Invasive Lobular Carcinoma 10 9 (90%) 1 (10%) 10 0 0.596 9 (90%) 1 (10%) 0.583